NanoCube
NanoCube Health is an early-stage Melbourne-based medical technology company developing innovative nanorobotics technology for the early detection, diagnosis, and treatment of pancreatic cancer. Leveraging artificial intelligence and nanotechnology at the nanoscale, their technology aims to detect pancreatic cancer at its earliest stage, monitor treatment progress in real-time, and deliver targeted therapies. Founded by Dr. Shawn Goussous and Lisa Milani, the company is focused on transforming oncology diagnostics and treatment through low-cost, accessible nanorobotics, addressing the critical need for early screening tools in pancreatic cancer, which currently has poor survival rates. NanoCube Health operates through collaborations and partnerships to accelerate development and commercialization, with a vision to improve survival and quality of life for patients with complex diseases.
NanoCube
NanoCube Health is an early-stage Melbourne-based medical technology company developing innovative nanorobotics technology for the early detection, diagnosis, and treatment of pancreatic cancer. Leveraging artificial intelligence and nanotechnology at the nanoscale, their technology aims to detect pancreatic cancer at its earliest stage, monitor treatment progress in real-time, and deliver targeted therapies. Founded by Dr. Shawn Goussous and Lisa Milani, the company is focused on transforming oncology diagnostics and treatment through low-cost, accessible nanorobotics, addressing the critical need for early screening tools in pancreatic cancer, which currently has poor survival rates. NanoCube Health operates through collaborations and partnerships to accelerate development and commercialization, with a vision to improve survival and quality of life for patients with complex diseases.